Pf bacteriophage is associated with decline in lung function in a longitudinal cohort of patients with cystic fibrosis and Pseudomonas airway infection
Pf may serve as a prognostic biomarker and potential therapeutic target for Pa infections in CF.
Authors
- Kayo Nakano
- Arya Khosravi (ORCID: https://orcid.org/0000-0002-4958-3556)
- Elizabeth B. Burgener (ORCID: https://orcid.org/0000-0001-8969-6232)
- Patrick R. Secor (ORCID: https://orcid.org/0000-0001-7123-3037)
- Lü Tian (ORCID: https://orcid.org/0000-0002-5893-0169)
- Michelle S. Bach (ORCID: https://orcid.org/0000-0002-3425-5234)
- Sophia L Gibbs
- Paul L. Bollyky (ORCID: https://orcid.org/0000-0003-2499-9448)
- Colleen Dunn
- Mary Catherine Sommers
- Carlos Milla (ORCID: https://orcid.org/0000-0001-5515-3053)
- Jacquelyn Spano (ORCID: https://orcid.org/0009-0005-6872-7155)
- Aditi Gupta (ORCID: https://orcid.org/0009-0001-7188-2536)
Institutions
- Children's Hospital of Los Angeles (US)
- Stanford Health Care (US)
- University of Montana (US)
- Stanford University (US)
Publication Details
- Journal
- Journal of Cystic Fibrosis
- Published
- 2024-10-24
- DOI
- https://doi.org/10.1016/j.jcf.2024.09.018
- Citations
- 5
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 2.09
Funders
- Georgia Clinical and Translational Science Alliance
- Emerson Collective
- National Institutes of Health
- National Heart, Lung, and Blood Institute
- National Center for Research Resources